With a broad range of technologies available in our 2 plants both FDA inspected and located in Italy and France, Zach is developing new generic APIs for all markets. We are able to manufacture Kilo-lab quantities as well as hundreds of tons of APIs. Our strong experience in filing all over the world is allowing us to support our customers on global basis.
Our portfolio is made of a mixture of large volume APIs like Gabapentin or N-AcetylCysteine and complex molecules like Nebivolol for which we have various patents.
Moreover, we have developed collaboration with an Indian company manufacturing some APIs in exclusivity for us based on process developed by Zach.